SB-429201
CAS No. 1027971-34-1
SB-429201 ( SB 429201;SB429201 )
Catalog No. M10136 CAS No. 1027971-34-1
A potent, selective HDAC1 inhibitor with IC50 of 1.5 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 314 | Get Quote |
|
50MG | 1602 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSB-429201
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent, selective HDAC1 inhibitor with IC50 of 1.5 uM.
-
DescriptionA potent, selective HDAC1 inhibitor with IC50 of 1.5 uM; increases histone acetylation in SW620 cells.
-
SynonymsSB 429201;SB429201
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1027971-34-1
-
Formula Weight436.51
-
Molecular FormulaC28H24N2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO=C(NC1=CC=C(OC2=CC=CC=C2)C=C1)C3=CC=C(NC(CCC4=CC=CC=C4)=O)C=C3
-
Chemical NameN-(4-phenoxyphenyl)-4-(3-phenylpropanamido)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hu E, et al. J Pharmacol Exp Ther. 2003 Nov;307(2):720-8.
molnova catalog
related products
-
AES-350
AES-350 is a potent and orally active HDAC6 inhibitor(IC50 and a Ki of 0.0244 μM and 0.035 μM, respectively).
-
Encorafenib
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
-
Cedryl acetate
The fungal transformation of cedryl acetate was investigated for the first time by using Cunninghamella elegans.